SARIN ARADHANA 4
4 · ALEXION PHARMACEUTICALS, INC. · Filed Dec 18, 2020
Insider Transaction Report
Form 4
SARIN ARADHANA
Chief Strategy & Business Off
Transactions
- Award
Common Stock, par value $.0001 per share
2020-12-16+15,371→ 48,830 total - Tax Payment
Common Stock, par value $.0001 per share
2020-12-16$157.96/sh−2,510$396,480→ 39,467 total - Tax Payment
Common Stock, par value $.0001 per share
2020-12-16$157.96/sh−6,853$1,082,500→ 41,977 total
Footnotes (3)
- [F1]Shares acquired on vesting of Performance Stock Units previously granted on February 28, 2018 under the 2017 Stock Incentive Plan.
- [F2]This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units.
- [F3]This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.